D-1849-2019 Class II Terminated
FDA drug recall D-1849-2019 was initiated by Pacifico National, Inc. dba AmEx Pharmacy on August 30, 2019 and is designated Class II. Reason for recall: Lack of assurance of sterility. The recall status is terminated (terminated October 8, 2020).
Recall Details
- Product Type
- Drugs
- Report Date
- September 18, 2019
- Initiation Date
- August 30, 2019
- Termination Date
- October 8, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
Product Description
Bevacizumab, 2.5 mg/0.1 mL, Norm-Ject Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901
Reason for Recall
Lack of assurance of sterility.
Distribution Pattern
Continental U.S. and Puerto Rico
Code Information
All lots remaining within expiry.